2005
DOI: 10.1016/j.ygyno.2005.07.068
|View full text |Cite
|
Sign up to set email alerts
|

Sentinel lymph node identification (SLNI) in the management of conservative surgery in early cervical cancer: Is it acceptable?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
11
1

Year Published

2006
2006
2013
2013

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 1 publication
0
11
1
Order By: Relevance
“…Positive PLNs have been reported as a major predictive factor of a high risk of PI (3,6,13,(22)(23)(24). However, in our study, only one patient with PI had positive SLN (macrometastases) while five had PI with negative PLN.…”
Section: ------------------------------------------------------------contrasting
confidence: 65%
See 2 more Smart Citations
“…Positive PLNs have been reported as a major predictive factor of a high risk of PI (3,6,13,(22)(23)(24). However, in our study, only one patient with PI had positive SLN (macrometastases) while five had PI with negative PLN.…”
Section: ------------------------------------------------------------contrasting
confidence: 65%
“…However, in our study, only one patient with PI had positive SLN (macrometastases) while five had PI with negative PLN. Rob et al reported that none of their negative-SLN patients with tumor size <3 cm had PI (24). In a subgroup of patients with tumor size <2 cm and stromal invasion <50%, Strnad et al found Table III.…”
Section: ------------------------------------------------------------mentioning
confidence: 99%
See 1 more Smart Citation
“…In other words, there may be a metastasis present in a regional non-sentinel lymph node that is not detected with SN ultrastaging. Low false-negative rates of SN staging in cervical cancer patients have been reported from single institutional experiences, especially in tumors smaller than 2 cm [6][7][8][9]. In contrast, a German multicenter validation study observed an unsatisfactory sensitivity of SN biopsy (77.7%); however, ultrastaging of SN had not been performed in this group's study, so important data on micrometastasis were missing for the analysis [10].…”
mentioning
confidence: 77%
“…The SLN procedure is now a widely accepted method of lymph node staging for selected cases of invasive breast cancer (3,4) and cutaneous melanoma (5). The concept is also being evaluated in numerous other types of cancer, including pelvic gynecologic (vulval, cervical, and endometrial) (6)(7)(8)(9), prostate (10), colon (11), gastric (12) and thyroid (13) cancer. In all cases, successful adaptation of the SLN procedure implies that the operator has a high identification rate and a low false-negative rate.…”
mentioning
confidence: 99%